Learn how to safely monitor your health after switching to generic medications, including tracking protocols, high-risk drug warnings, and understanding bioequivalence standards.
Narrow therapeutic index drugs require stricter bioequivalence standards to prevent dangerous side effects or treatment failure. Learn how the FDA, EMA, and Health Canada regulate generics of critical medications like warfarin and levothyroxine.
Switching between generic medications is common and usually safe - but not for all drugs. Learn which medications are at risk and how to protect yourself from dangerous changes in effectiveness or side effects.